Bernards: #ampeurope2018 And MEK inh, only 1/2 w/BRAFi, V600E not limited to melanoma. CRC: Vemurafenib not useful… https://t.co/Z63vPjVIxG

2:50am May 1st 2018 via Twitter Web Client